Actively Recruiting
Evaluating Disparities in Precision Oncology
Led by Indiana University · Updated on 2025-06-13
10600
Participants Needed
1
Research Sites
253 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a non-randomized observational trial designed to collect detailed clinical, social determinant, and genomic data from patients enrolled in molecular oncology tumor boards across four comprehensive cancer centers.
CONDITIONS
Official Title
Evaluating Disparities in Precision Oncology
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Ability to provide written informed consent and HIPAA authorization
- Patients must be �3E= 18 years old at the time of consent
- Patients planning to undergo molecular testing as part of their routine cancer care
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Indiana University Health Melvin and Bren Simon Comprehensive Cancer Center
Indianapolis, Indiana, United States, 46202
Actively Recruiting
Research Team
M
Maria McQuade, BA
CONTACT
B
Bryan P Schneider, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here